Last Updated On 4/8/2022 4:56:05 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| Company: Acerta Pharma/AstraZeneca |
| Recipient: You |
| Company: Roche/Genentech |
| Recipient: You |
| Company: Morphosys |
| Recipient: You |
| Company: Conjupro Biotherapeutics |
| Recipient: You |
| Company: Octernal |
| Recipient: You |
| Company: Johnson and Johnson |
| Recipient: You |
| Company: MEI Pharma |
| Recipient: You |
| Company: Lilly |
| Recipient: You |
|
| Consulting or Advisory Role |
| No Relationships to Disclose |
|
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Loxo |
| Recipient: You |
| Company: Epizyme |
| Recipient: You |
| Company: Celgene |
| Recipient: Your Institution |
| Company: Incyte |
| Recipient: Your Institution |
| Company: Acerta Pharma |
| Recipient: Your Institution |
| Company: Kite Pharma |
| Recipient: Your Institution |
| Company: Seattle Genetics |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Bristol-Myers Squibb |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|